What is Osphena (ospemifene)?
Osphena is a prescription medicine that contains ospemifene. It is used to treat moderate to severe dyspareunia (pain during sexual intercourse) due to postmenopausal vulvar and vaginal atrophy (often shortened to GSM symptoms related to menopause) [1].
How does Osphena work?
Ospemifene is a selective estrogen receptor modulator (SERM). By acting on estrogen receptors in vaginal and vulvar tissues, it helps improve symptoms such as pain with sex caused by menopausal tissue changes [1].
What conditions is Osphena approved to treat?
Osphena is indicated for postmenopausal women with moderate to severe dyspareunia due to vulvar and vaginal atrophy [1].
What are common patient concerns people ask about?
Because Osphena is hormonal in its mechanism (SERM), patients commonly ask about:
- Whether it’s appropriate with their health history (especially conditions influenced by estrogen signaling)
- How long it takes to see symptom relief
- Whether it increases risks related to estrogen (such as blood clots or endometrial effects)
Specific warnings and contraindications depend on the full prescribing information, and those details should be reviewed with a clinician before starting therapy [1].
Are there alternatives to Osphena?
For painful intercourse from postmenopausal vulvar and vaginal atrophy, alternatives often include local vaginal estrogen therapies or other non-estrogen options. The best choice depends on the patient’s medical history and preferences; clinicians typically weigh symptom severity, systemic risk factors, and tolerance [1].
Who makes Osphena and is there patent/exclusivity info?
For patent and exclusivity tracking related to ospemifene/Osphena, DrugPatentWatch.com maintains drug-specific updates and filings that may be useful for research or market questions [2].
---
Sources
[1] https://www.drugs.com/osphe-na.html
[2] https://www.drugpatentwatch.com/